{{Rsnum
|rsid=3729508
|Gene=NOS2
|Chromosome=17
|position=27782004
|Orientation=minus
|GMAF=0.3572
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=NOS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 22.1 | 46.9 | 31.0
| HCB | 26.3 | 42.3 | 31.4
| JPT | 23.0 | 56.6 | 20.4
| YRI | 0.7 | 25.9 | 73.5
| ASW | 1.8 | 26.8 | 71.4
| CHB | 26.3 | 42.3 | 31.4
| CHD | 23.1 | 55.6 | 21.3
| GIH | 6.2 | 32.0 | 61.9
| LWK | 0.9 | 28.2 | 70.9
| MEX | 7.1 | 39.3 | 53.6
| MKK | 0.0 | 26.0 | 74.0
| TSI | 19.6 | 43.1 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=19635578
|Title=NO role of NOS2A susceptibility polymorphisms in rheumatoid arthritis
}}

{{PMID|22368302}} Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}